SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-025024
Filing Date
2022-11-14
Accepted
2022-11-14 17:13:36
Documents
71
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q apgn-20220930.htm   iXBRL 10-Q 3490126
2 EX-31.1 apgn-ex31_1.htm EX-31.1 34080
3 EX-31.2 apgn-ex31_2.htm EX-31.2 34077
4 EX-32.1 apgn-ex32_1.htm EX-32.1 15188
5 EX-32.2 apgn-ex32_2.htm EX-32.2 15122
6 GRAPHIC img172445371_0.jpg GRAPHIC 40106
  Complete submission text file 0000950170-22-025024.txt   10935174

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apgn-20220930_pre.xml EX-101.PRE 378188
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT apgn-20220930_cal.xml EX-101.CAL 37582
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apgn-20220930_def.xml EX-101.DEF 306532
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apgn-20220930.xsd EX-101.SCH 69528
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apgn-20220930_lab.xml EX-101.LAB 494707
65 EXTRACTED XBRL INSTANCE DOCUMENT apgn-20220930_htm.xml XML 1952964
Mailing Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070
Business Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070 650.931.6236
Apexigen, Inc. (Filer) CIK: 0001814140 (see all company filings)

IRS No.: 851260244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39488 | Film No.: 221387594
SIC: 2834 Pharmaceutical Preparations